Search results for:
If you're not happy with the results, please do another search.
Abalone and Pfizer Partner on Rare Activating Antibodies
Abalone Bio, which is a therapeutics biotech company that distinctively measures and also makes utmost use of large-scale activity datasets in order to discover...
Samsung Bioepis Starts Direct Commercialization of Byooviz
Samsung Bioepis has begun its direct commercialization of Byooviz, which is a biosimilar to Genentech’s Lucentis - ranibizumab in Europe.
The company has gone ahead...
Daiichi Sankyo Plans to Boost Its Antibody-Drug Conjugate
Daiichi Sankyo has recently made an announcement of its plans to invest almost 300 billion yen, which is equivalent to $1.9 billion, when it...